Intermittent versus continuous phototherapy for the treatment of neonatal non-hemolytic moderate hyperbilirubinemia in infants more than 37 weeks of gestational age: a randomized controlled trial
Not Applicable
- Conditions
- Icter.P55-59
- Registration Number
- IRCT2015112225184N1
- Lead Sponsor
- oghman Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
This study has been performed on 60 neonates with indirect hyperbilirubinemia; iInclusion criteria are gestational age above 37 weeks and absence of other concomittant diseases such as hemolysis and upper limit of their bilirubin are 18 mg/dl.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Bilirubin. Timepoint: pretreatment and 6 hours after phototherapy. Method of measurement: blood sampling.;Melatonin. Timepoint: after depletion of bilirubin. Method of measurement: special kit and blood sampling.
- Secondary Outcome Measures
Name Time Method Kernicterus. Timepoint: during of treatment. Method of measurement: sign and symptoms.;Complications. Timepoint: at the end of treatment. Method of measurement: observation.;Duration of phototherapy. Timepoint: at the end of treatment. Method of measurement: observation.;Hospital lenght of stay. Timepoint: at the end of treatment. Method of measurement: observation.;Melatonin. Timepoint: at the end of treatment. Method of measurement: blood sampling.